Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -.--% |
2020 | PAO Group, Inc. completed the acquisition of NCM Biotech from Kali, Inc.. | CI |
2020 | PAO Group, Inc. agreed to acquire NCM Biotech from Kali, Inc.. | CI |
Financials (USD)
Sales 2011 | 88.83M | Sales 2012 | 94.55M | Capitalization | 9.63M |
---|---|---|---|---|---|
Net income 2011 | 13M | Net income 2012 | 17M | EV / Sales 2011 | 0.24 x |
Net cash position 2011 | 14.72M | Net cash position 2012 | 26.92M | EV / Sales 2012 | -0.18 x |
P/E ratio 2011 |
2.66
x | P/E ratio 2012 |
0.55
x | Employees | 171 |
Yield 2011 * |
-
| Yield 2012 |
-
| Free-Float | 98.86% |
Managers | Title | Age | Since |
---|---|---|---|
Frederick Ferri
CEO | Chief Executive Officer | - | 18-12-18 |
1st Jan change | Capi. | |
---|---|---|
-.--% | 1.54K | |
+47.86% | 779B | |
+41.07% | 631B | |
-6.85% | 354B | |
+19.97% | 333B | |
+9.76% | 301B | |
+16.89% | 249B | |
-1.84% | 216B | |
+10.85% | 214B | |
+4.72% | 163B |
- Stock Market
- Equities
- KALY Stock